The Cigna Group (NYSE:CI – Get Free Report) had its price objective lowered by investment analysts at Truist Financial from $390.00 to $375.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the health services provider’s stock. Truist Financial’s price objective suggests a potential upside of 28.07% from the company’s previous close.
A number of other research firms also recently weighed in on CI. Barclays decreased their target price on shares of The Cigna Group from $420.00 to $339.00 and set an “overweight” rating for the company in a research report on Friday. UBS Group decreased their target price on shares of The Cigna Group from $410.00 to $390.00 and set a “buy” rating for the company in a research report on Monday. Raymond James reissued a “strong-buy” rating and set a $360.00 target price (down previously from $415.00) on shares of The Cigna Group in a research report on Friday. Cantor Fitzgerald decreased their target price on shares of The Cigna Group from $400.00 to $350.00 and set an “overweight” rating for the company in a research report on Friday. Finally, Stephens cut their price target on The Cigna Group from $410.00 to $380.00 and set an “overweight” rating on the stock in a report on Friday. Two equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $376.63.
View Our Latest Analysis on CI
The Cigna Group Trading Up 0.1 %
The Cigna Group (NYSE:CI – Get Free Report) last released its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same period last year, the company posted $6.79 earnings per share. Sell-side analysts expect that The Cigna Group will post 29.66 earnings per share for the current fiscal year.
Institutional Investors Weigh In On The Cigna Group
Large investors have recently added to or reduced their stakes in the company. Collier Financial bought a new position in The Cigna Group in the 4th quarter worth about $32,000. ORG Wealth Partners LLC bought a new position in The Cigna Group in the 4th quarter worth about $34,000. Ulland Investment Advisors LLC boosted its stake in The Cigna Group by 2,500.0% in the 3rd quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock worth $36,000 after purchasing an additional 100 shares during the period. Prospera Private Wealth LLC bought a new position in The Cigna Group in the 3rd quarter worth about $37,000. Finally, Compagnie Lombard Odier SCmA bought a new stake in shares of The Cigna Group during the 4th quarter valued at about $37,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.
The Cigna Group Company Profile
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
See Also
- Five stocks we like better than The Cigna Group
- How to Calculate Inflation Rate
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
- What is the Nikkei 225 index?
- High-Yield Dividend King PepsiCo Offers Value Too Good to Ignore
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.